Company intelligence / Profile preview

Iris Pharma

La Gaude, Provence-Alpes-Côte d'Azur, Franceiris-pharma.com ↗

Ownership: Private
Employees: ~91
Development stage: Commercial

Overview

Iris Pharma is an independent contract research organization specializing exclusively in ophthalmology. Since its founding in France in 1989, it has supported the development and regulatory approval of more than seventy ocular drugs and medical devices globally. The company offers comprehensive preclinical and clinical research services—including GLP studies, bioanalysis, formulation development, consulting—and has built strong relationships with key opinion leaders and investigative sites worldwide. Its expertise covers all stages of drug/device development for eye health.

Therapeutic areas: OphthalmologyInfectious Diseases
Modalities: Small moleculeBiologicDevice
Industry: Contract Research Organization

Beyond the preview

Go deeper on Iris Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iris Pharma.

Explore the full profile